Literature DB >> 12569174

Microsatellite instability and defects in mismatch repair proteins: a new aetiology for Sertoli cell-only syndrome.

M R Maduro1, R Casella, E Kim, N Lévy, C Niederberger, L I Lipshultz, D J Lamb.   

Abstract

Microsatellite instability is characteristic of certain types of cancer, and is present in rodents lacking specific DNA mismatch repair proteins. These azoospermic mice exhibit spermatogenic defects similar to some human testicular failure patients. Therefore, we hypothesized that microsatellite instability due to deficiencies in mismatch repair genes might be an unrecognized aetiology of human testicular failure. Because these azoospermic patients are candidates for testicular sperm extraction and ICSI, transmission of mismatch repair defects to the offspring is possible. Seven microsatellite loci were analysed for instability in specimens from 41 testicular failure patients and 20 controls. Blood and testicular DNA were extracted from patient and control specimens, and amplified by PCR targeting seven microsatellite loci. DNA fragment length was analysed with an ABI Prism 310 Genotyping Machine and GeneScan software. Immunohistochemistry was performed on paraffinized testis biopsy sections and cultured testicular fibroblasts from each patient to determine if expression of the mismatch repair proteins hMSH2 and hMLH1 was normal in both somatic and germline cells. Results demonstrate that microsatellite instability and DNA mismatch repair protein defects are present in some azoospermic men, predominantly in Sertoli cell-only patients (P < 0.01 and P < 0.05 respectively). This provides evidence of a previously unrecognized aetiology of testicular failure that may be associated with cancer predisposition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12569174     DOI: 10.1093/molehr/gag013

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  16 in total

Review 1.  Intracytoplasmic sperm injection (ICSI)--what are the risks?

Authors:  Joseph P Alukal; Dolores J Lamb
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

Review 2.  Male reproductive health and prostate cancer risk.

Authors:  Thomas J Walsh
Journal:  Curr Opin Urol       Date:  2011-11       Impact factor: 2.309

3.  Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.

Authors:  Christiane Rudolph; Cecilie Melau; John E Nielsen; Kristina Vile Jensen; Dekang Liu; Javier Pena-Diaz; Ewa Rajpert-De Meyts; Lene Juel Rasmussen; Anne Jørgensen
Journal:  Cell Oncol (Dordr)       Date:  2017-05-23       Impact factor: 6.730

4.  Increased risk of cancer among azoospermic men.

Authors:  Michael L Eisenberg; Paul Betts; Danielle Herder; Dolores J Lamb; Larry I Lipshultz
Journal:  Fertil Steril       Date:  2013-06-21       Impact factor: 7.329

Review 5.  Fertility preservation in men with cancer.

Authors:  Koji Chiba; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2014-04-26

Review 6.  Urologic conditions associated with malignancy.

Authors:  Eric M Lo; James M Hotaling; Alexander W Pastuszak
Journal:  Urol Oncol       Date:  2019-01-02       Impact factor: 3.498

Review 7.  DNA mismatch repair and infertility.

Authors:  Sarmistha Mukherjee; Alex D Ridgeway; Dolores J Lamb
Journal:  Curr Opin Urol       Date:  2010-11       Impact factor: 2.309

8.  Increased risk of testicular germ cell cancer among infertile men.

Authors:  Thomas J Walsh; Mary S Croughan; Michael Schembri; June M Chan; Paul J Turek
Journal:  Arch Intern Med       Date:  2009-02-23

Review 9.  Impact of DNA mismatch repair system alterations on human fertility and related treatments.

Authors:  Min-hao Hu; Shu-yuan Liu; Ning Wang; Yan Wu; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

10.  Cancer risk in first- and second-degree relatives of men with poor semen quality.

Authors:  Ross E Anderson; Heidi A Hanson; Darshan P Patel; Erica Johnstone; Kenneth I Aston; Douglas T Carrell; William T Lowrance; Ken R Smith; James M Hotaling
Journal:  Fertil Steril       Date:  2016-06-20       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.